eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank
 
MEiN
70
INDEX COPERNICUS
126.31

GOOGLE H5
22

VIEW ARTICLES
Indexed in:
ESCI

Web of Science
Clarivate Analytics
JCI
0.27

Journal Citation Indicator
CiteScore 2021
2.8
 
1/2022
vol. 26
 
the latest issue:
 

 
Review paper

Oxidative stress in melanogenesis and melanoma development

Kacper Kamiński, Urszula Kazimierczak, Tomasz Kolenda
Contemp Oncol (Pozn) 2022; 26 (1): 1–7
Online publish date: 2022-02-04
 
DOI: https://doi.org/10.5114/wo.2021.112447
Review paper

Research highlights on contributions of mitochondrial DNA microsatellite instability in solid cancers – an overview

Abdul Aziz Mohamed Yusoff, Siti Muslihah Abd Radzak, Siti Zulaikha Nashwa Mohd Khair
Contemp Oncol (Pozn) 2022; 26 (1): 8–26
Online publish date: 2022-03-30
 
DOI: https://doi.org/10.5114/wo.2022.115674
Original paper

Soluble B7H3 level in breast cancer and its relationship with clinicopathological variables and T-cell infiltration

Okan Avci, Eyyup Çavdar, Yakup İriağaç, Kubilay Karaboyun, Aliye Çelikkol, Tuğba İlkem Kurtoğlu Özçağlaya, Meltem Öznur, Sibel Özkan Gürdal, Erdoğan Selçuk Şeber
Contemp Oncol (Pozn) 2022; 26 (1): 27–31
Online publish date: 2022-02-11
 
DOI: https://doi.org/10.5114/wo.2022.113502
Original paper

Bevacizumab in metastatic colorectal cancer in a real-life setting – toxicity profile, survival outcomes, and impact of tumor sidedness

Hind Chibani, Khalid El Bairi, Ouissam Al Jarroudi, Said Afqir
Contemp Oncol (Pozn) 2022; 26 (1): 32–39
Online publish date: 2022-03-18
 
DOI: https://doi.org/10.5114/wo.2022.114678
Original paper

Gut microbiome as a potential biomarker of cancer risk in inflammatory bowel disease

Ryan Lane Jones
Contemp Oncol (Pozn) 2022; 26 (1): 40–43
Online publish date: 2022-03-16
 
DOI: https://doi.org/10.5114/wo.2022.114537
Original paper

Patient satisfaction and cost analysis of telehealth delivered by allied health oncology clinicians

Emma Charters, Maite J. Khom, Jacqueline Baker, Toni Lindsay
Contemp Oncol (Pozn) 2022; 26 (1): 44–48
Online publish date: 2022-03-29
 
DOI: https://doi.org/10.5114/wo.2022.115047
Original paper

Prognostic values of myeloid differentiation factor 88 (MYD88) and transducin (β)-like receptor 1 (TBLR1) expression in tissues of diffuse large B-cell non-Hodgkin lymphoma patients – an immunohistochemical study

Asmaa Hussein Mohamed, Mariem A. Elfeky, Shereen Elshorbagy, Nabila Hefzi, Tamer Oraby, Waleed A. Abdelhady, Mahmoud Sharaf Eldein, Ahmed Embaby, Ehab M. Oraby
Contemp Oncol (Pozn) 2022; 26 (1): 49–58
Online publish date: 2022-03-30
 
DOI: https://doi.org/10.5114/wo.2022.115675
Original paper

Modern-era radiotherapy and ischaemic heart disease-related mortality outcomes in Asian breast-cancer patients

Ling Fung Nelson Yit, Choon Ta Ng, Fuh Yong Won, Zubin Master, Siqin Zhou, Wee Loon Ng
Contemp Oncol (Pozn) 2022; 26 (1): 59–68
Online publish date: 2022-03-30
 
DOI: https://doi.org/10.5114/wo.2022.115676
Original paper

Prognostic significance of lymphocyte-to-monocyte ratio in patients with classical Hodgkin lymphoma before and after receiving first-line chemotherapy

Heba F. Taha, Lamiaa Mahmoud Kamel, Ahmed Embaby, Lobna A. Abdelaziz
Contemp Oncol (Pozn) 2022; 26 (1): 69–77
Online publish date: 2022-03-30
 
DOI: https://doi.org/10.5114/wo.2022.115459
Original paper

Clinical significance of cytokeratin 19 and OCT4 as survival markers in non-metastatic and metastatic breast cancer patients

Lobna A. Abdelaziz, Huda F. Ebian, Ola A. Harb, Yousef Nosery, Heba F. Taha, Nashwa Nawar
Contemp Oncol (Pozn) 2022; 26 (1): 78–87
Online publish date: 2022-03-30
 
DOI: https://doi.org/10.5114/wo.2022.115678
Letter to the Editor

A long-term responding epidermal growth factor receptor mutated non-small cell lung cancer patient with extremely high mutation allele frequency

Kunihiko Miyazaki, Yoshiharu Sato, Hiroaki Satoh, Nobuyuki Hizawa
Contemp Oncol (Pozn) 2022; 26 (1): 88–89
Online publish date: 2022-03-30
 
DOI: https://doi.org/10.5114/wo.2022.115447
Quick links
© 2022 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.